Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G T Morris, Barry S Taylor, Trever G Bivona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells
Prajwal Rajappa, William S Cobb, Emma Vartanian, et al.
The Journal of Clinical Investigation
|
October 12, 2018
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei, Anantha Marisetty, Brett Schrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Rupa Juthani, Brian Madajewski, Barney Yoo, et al.
Neuro-Oncology
|
October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski, Howard Colman, John F De Groot, et al.
Neuro-Oncology
|
August 21, 2023
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics
Peter Kan, Visish M Srinivasan, Joy Gumin, et al.
The Journal of Clinical Investigation
|
April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma
Yujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.
Neuro-Oncology
|
August 10, 2024
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
Pravesh Gupta, Minghao Dang, Shivangi Oberai, et al.
Neuro-Oncology
|
November 23, 2019
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
John de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, et al.
The Lancet. Oncology
|
October 3, 2024
A brave new framework for glioma drug development
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G T Morris, Barry S Taylor, Trever G Bivona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells
Prajwal Rajappa, William S Cobb, Emma Vartanian, et al.
The Journal of Clinical Investigation
|
October 12, 2018
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei, Anantha Marisetty, Brett Schrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Rupa Juthani, Brian Madajewski, Barney Yoo, et al.
Neuro-Oncology
|
October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski, Howard Colman, John F De Groot, et al.
Neuro-Oncology
|
August 21, 2023
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics
Peter Kan, Visish M Srinivasan, Joy Gumin, et al.
The Journal of Clinical Investigation
|
April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma
Yujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.
Neuro-Oncology
|
August 10, 2024
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
Pravesh Gupta, Minghao Dang, Shivangi Oberai, et al.
Neuro-Oncology
|
November 23, 2019
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
John de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, et al.
The Lancet. Oncology
|
October 3, 2024
A brave new framework for glioma drug development
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Page
of 4